Infographic: The 7 FDA-Approved Biosimilars

The FDA has approved, to date, 7 biosimilar treatments.

The FDA has approved, to date, 7 biosimilar treatments.

Related Content:

OncologyRheumatologyGastroenterology
Subcutaneous Infliximab CT-P13 Superior to Placebo as Maintenance Therapy for IBD
Challenges, Obstacles, and Future Directions for Anti-TNF Biosimilars in IBD
Skyrizi Overtakes Humira: “Product Hopping” Leaves Biosimilar Market in Limbo